AI strategy for healthcare providers
How a clinic or care provider should approach AI: administrative gains first, clinical support within regulation, clinicians in charge.
The short answer
An AI strategy for a healthcare provider separates three domains that are often confused. Administration, where AI and automation deliver large, low-risk gains: booking, reminders, intake, document handling, recall, billing, reporting. Clinical documentation, where assistive AI helps, transcribing and drafting notes, suggesting codes, drafting letters, with a clinician reviewing and signing everything that enters the record. And clinical decision-making, where only tools regulated as medical devices for that purpose belong, adopted through clinical governance, with clinicians trained and accountable. Two facts shape every choice: health data is special category data under data protection law, and in the EU most AI touching clinical decisions is high-risk under the AI Act. The largest realistic gains are hours returned to patients, and they come from the first two domains. Nothing enters the record or reaches a patient without a clinician’s review, every tool touching health data runs under a health-appropriate processing agreement, and a named clinical and data protection lead owns the register of uses.
The three domains
| Domain | Uses | Risk and regulation | Conditions |
|---|---|---|---|
| Administration | Booking, reminders, intake into the record, document classification, recall, billing, reporting | Low; data protection applies | Health data only in appropriate systems; impact assessment where required per flow |
| Clinical documentation | Transcription and draft notes; coding suggestions; referral and patient letters; summaries of records for the clinician | Medium; data protection; may touch AI Act obligations depending on function | Clinician reviews and signs everything; health-appropriate processing agreement; audit trail |
| Clinical decision support | Diagnostic aids, triage scoring, treatment suggestions | High; medical device regulation; AI Act high-risk | Regulated tools only; clinical governance; training; accountability; patient information |
Building the strategy
- Appoint the leads: a clinician for clinical governance and the data protection officer or adviser for data.
- Register every AI use, including the informal ones staff have adopted, and stop any that touch health data through consumer tools today.
- Start in administration: booking, reminders, intake, documents, recall. Measure no-shows, calls and hours.
- Assess impact before each flow with the data protection lead, and document it.
- Introduce documentation assistance on health-appropriate services, with review and signature built into the workflow, and pilot with willing clinicians.
- Inform patients plainly about how AI is used in their care and their data.
- Treat clinical decision tools as medical device procurement, through governance, not as software adoption.
- Review quarterly: incidents, time returned, clinician feedback, patient feedback, regulatory changes.
What the provider gains
Clinicians who spend less of the consultation typing and less of the evening on notes. Reception with fewer calls and fewer no-shows. Records that are complete, coded and current. Letters that go out the same day. Recalls that happen on time. Billing that closes faster. None of it required a machine to make a clinical judgement, and all of it returned time to the people who do.
What this means for you
Approach AI in healthcare by domain: administration first for large, low-risk gains; clinical documentation with assistive tools that a clinician reviews and signs; clinical decision support only through regulated tools and governance. Keep health data in appropriate systems under health-appropriate agreements, assess impact before each flow, inform patients, and put a clinical and a data protection lead in charge of the register. The hours come back to patient care, and the trust that care depends on stays intact.
Frequently asked questions
Can AI help with diagnosis in our practice?
Only through tools that are regulated as medical devices for that purpose, adopted through proper governance, with clinicians trained and accountable, and under the AI Act's high-risk obligations. That is a procurement and clinical governance decision, not an IT one, and it is a minority of what AI can do for a provider. The majority, and the place to start, is the administrative and documentation burden that keeps clinicians from patients.
Where does AI safely save time in a clinic?
In the work around care: online booking and reminders, pre-visit intake into the record, transcription and drafting of consultation notes for the clinician to review and sign, clinical coding suggestions, referral and patient letters drafted from the record, document classification and filing, recall scheduling, billing and reporting. Each keeps the clinician responsible for the record, runs on health-appropriate services, and returns hours every week.
What are the non-negotiables?
Health data only in systems and services with health-appropriate processing agreements and security, never in consumer tools. A clinician reviews and signs anything entering the record or reaching a patient. A check against Article 35 on whether an impact assessment is required before new flows, and one where it is. Clear information to patients about how AI is used. Regulated tools only for clinical decisions. And a named clinical and data protection lead who owns the register of AI uses.
Sources
- European Commission: AI Act (accessed 2026-09-12)
- Autoriteit Persoonsgegevens: Health data (accessed 2026-09-12)